vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Dominari Holdings Inc. (DOMH). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $19.2M, roughly 1.6× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -438.1%, a 431.3% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 34.7%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs 36.8%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
APYX vs DOMH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $30.1M |
| Net Profit | $-1.3M | $-131.8M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | -8.9% |
| Net Margin | -6.8% | -438.1% |
| Revenue YoY | 34.7% | 220.4% |
| Net Profit YoY | 71.9% | -12426.2% |
| EPS (diluted) | — | $-6.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $30.1M | ||
| Q3 25 | $12.9M | $50.8M | ||
| Q2 25 | $11.4M | $34.1M | ||
| Q1 25 | $9.4M | $8.1M | ||
| Q4 24 | $14.2M | $9.4M | ||
| Q3 24 | $11.5M | $4.0M | ||
| Q2 24 | $12.1M | $6.2M | ||
| Q1 24 | $10.2M | $1.4M |
| Q4 25 | $-1.3M | $-131.8M | ||
| Q3 25 | $-2.0M | $125.2M | ||
| Q2 25 | $-3.8M | $16.6M | ||
| Q1 25 | $-4.2M | $-32.5M | ||
| Q4 24 | $-4.6M | $1.1M | ||
| Q3 24 | $-4.7M | $-4.2M | ||
| Q2 24 | $-6.6M | $-6.1M | ||
| Q1 24 | $-7.6M | $-5.4M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | -8.9% | ||
| Q3 25 | -6.5% | -3.1% | ||
| Q2 25 | -22.6% | -57.0% | ||
| Q1 25 | -32.4% | -394.6% | ||
| Q4 24 | -21.4% | 0.4% | ||
| Q3 24 | -31.6% | -79.1% | ||
| Q2 24 | -45.7% | -44.3% | ||
| Q1 24 | -64.6% | -205.2% |
| Q4 25 | -6.8% | -438.1% | ||
| Q3 25 | -15.4% | 246.4% | ||
| Q2 25 | -33.2% | 48.7% | ||
| Q1 25 | -44.0% | -400.5% | ||
| Q4 24 | -32.5% | 11.4% | ||
| Q3 24 | -40.9% | -104.2% | ||
| Q2 24 | -54.0% | -99.1% | ||
| Q1 24 | -74.0% | -398.0% |
| Q4 25 | — | $-6.94 | ||
| Q3 25 | — | $7.27 | ||
| Q2 25 | — | $1.12 | ||
| Q1 25 | — | $-3.02 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | — | $-0.67 | ||
| Q2 24 | $-0.19 | $-1.01 | ||
| Q1 24 | $-0.22 | $-0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $80.5M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $69.4M |
| Total Assets | $66.8M | $112.9M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $80.5M | ||
| Q3 25 | $25.1M | $176.2M | ||
| Q2 25 | $29.3M | $28.2M | ||
| Q1 25 | $31.0M | $18.9M | ||
| Q4 24 | $31.7M | $8.2M | ||
| Q3 24 | $28.0M | $7.2M | ||
| Q2 24 | $32.7M | $12.1M | ||
| Q1 24 | $37.3M | $7.1M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $69.4M | ||
| Q3 25 | $5.8M | $210.2M | ||
| Q2 25 | $7.3M | $88.6M | ||
| Q1 25 | $10.5M | $42.4M | ||
| Q4 24 | $14.2M | $39.9M | ||
| Q3 24 | $11.0M | $38.3M | ||
| Q2 24 | $14.7M | $42.4M | ||
| Q1 24 | $20.3M | $47.7M |
| Q4 25 | $66.8M | $112.9M | ||
| Q3 25 | $57.4M | $223.4M | ||
| Q2 25 | $58.2M | $109.3M | ||
| Q1 25 | $60.2M | $52.3M | ||
| Q4 24 | $64.8M | $47.1M | ||
| Q3 24 | $60.7M | $43.4M | ||
| Q2 24 | $65.4M | $49.1M | ||
| Q1 24 | $70.7M | $52.2M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $22.7M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $22.7M | ||
| Q3 25 | $-3.5M | $-4.9M | ||
| Q2 25 | $-1.2M | $-353.0K | ||
| Q1 25 | $-702.0K | $1.2M | ||
| Q4 24 | $-2.9M | $-16.7M | ||
| Q3 24 | $-4.4M | $-4.7M | ||
| Q2 24 | $-4.3M | $1.4M | ||
| Q1 24 | $-6.3M | $-8.6M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.04× | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
